Citation Impact
Citing Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Differential diagnosis of suspected multiple sclerosis: a consensus approach
2008
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
2007
Astrocytes: biology and pathology
2009 Standout
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
2011
Glutamate receptor ion channels
2005 Standout
Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia
2005
Electro‐Oculography, Electroretinography, Visual Evoked Potentials, and Multifocal Electroretinography in Patients with Vigabatrin‐Attributed Visual Field Constriction
2000
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Alpha-band oscillations, attention, and controlled access to stored information
2012 Standout
Myasthenia Gravis
2016 Standout
The spectrum of neuromyelitis optica
2007 Standout
EEG and ERP assessment of normal aging
1997
Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease
1994
On the relationship between EEG and P300: individual differences, aging, and ultradian rhythms
1997
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial
2003
Glutamate uptake
2001 Standout
Pathobiology of ischaemic stroke: an integrated view
1999 Standout
Ophthalmic manifestations of IgG4-related disease: Single-center experience and literature review
2013
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
On the relationship between EEG and ERP variability
1995
Abnormalities of the Left Temporal Lobe and Thought Disorder in Schizophrenia
1992 Standout
The Relationship Between Prestimulus Alpha Amplitude and Visual Evoked Potential Amplitude
1991
Updating P300: An integrative theory of P3a and P3b
2007 Standout
Autoimmunity in Stiff‐Man Syndrome with breast cancer is targeted to the C‐terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161
1994
Guillain-Barré syndrome
2016 Standout
Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)
1997 Standout
Neuromuscular junction disorders
2016
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravis
1997
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Mycophenolate mofetil in AChR‐antibody‐positive myasthenia gravis: Outcomes in 102 patients
2010
Myasthenia gravis
2000 Standout
Amyotrophic lateral sclerosis
2011 Standout
EEG responses to combined somatosensory and transcranial magnetic stimulation
2001
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Prestimulus Eeg-Activity Strongly Influences the Auditory Evoked Vertex Response: A New Method for Selective Averaging
1993
Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysis
1994
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
EEG alpha oscillations: The inhibition–timing hypothesis
2006 Standout
Multiple sclerosis
2008 Standout
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
2012
Demyelinating diseases
2006
Alpha rhythm of the EEG modulates visual detection performance in humans
2004
Exploration of machine learning techniques in predicting multiple sclerosis disease course
2017
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
CT Abnormalities in Schizophrenia
1989
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Cerebral ischemia and inflammation
2001
Efficacy of Low-Dose FK506 in the Treatment of Myasthenia gravis – A Randomized Pilot Study
2005
Autoantibodies to a 128-kd Synaptic Protein in Three Women with the Stiff-Man Syndrome and Breast Cancer
1993
Stroke
2008 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Direct and mediated associations between P300 amplitude in childhood and substance use disorders outcome in young adulthood
2004
Amyotrophic Lateral Sclerosis and Life-Sustaining Therapy: Patients' Desires for Information, Participation in Decision Making, and Life-Sustaining Therapy
1991
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders
2000
Tuberous sclerosis
2008 Standout
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study
1998
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Vigabatrin
1991
Pre-stimulus spectral EEG patterns and the visual evoked response
1991
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
1999
Trigeminal neuralgia: Pathology and pathogenesis
2001 Standout
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
IgG4-related disease
2014 Standout
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
2002
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Brain-stem trigeminal and auditory evoked potentials in multiple sclerosis: physiological insights
1996
Neuroprotection in Acute Ischaemic Stroke
1999
Extended Cervicomediastinal Thymectomy in the Integrated Management of Myasthenia Gravis
1997
On the relationship between background EEG and the P300 event-related potential
1994
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder
2008 Standout
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Enhancement of Visual Evoked Potentials by Stimulation During Low Prestimulus Eeg Stages
1993
Meta‐analysis of P300 and schizophrenia: Patients, paradigms, and practical implications
2003
Le potentiel évoqué cognitif P300 (II) : variabilité interindividuelle et application clinique en psychopathologie
2000
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) [RETIRED]
2000
Aquaporin‐4 Antibodies (NMO ‐IgG ) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
2013
Genetic Analysis of Default Mating Behavior in Saccharomyces cerevisiae
1997 StandoutNobel
Thymectomy for non-thymomatous myasthenia gravis
2013
Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing
2013
Cytokines and Cell Adhesion Molecules in Cerebral Ischemia
1998
Cognitive effects of vigabatrin
1996
Plasma exchange for generalised myasthenia gravis
2002
Intravenous immunoglobulin for myasthenia gravis
2012
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
1998 Standout
Apoptotic Mechanisms After Cerebral Ischemia
2009 Standout
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
2000 Standout
Inflammatory Markers and Onset of Cardiovascular Events
2003 Standout
Field-specific visual-evoked potentials
2002
Asymmetric Transition-Metal-Catalyzed Allylic Alkylations: Applications in Total Synthesis
2003 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of V. Cosi being referenced
ICHD-II Diagnostic Criteria for Tolosa—Hunt Syndrome in Idiopathic Inflammatory Syndromes of the Orbit and/or the Cavernous Sinus
2008
Antigen-specific oligoclonal IgG in AIDS-related cytomegalovirus and toxoplasma encephalitis
1996
Prestimulus spectral EEG patterns and the evoked auditory vertex response
1988
P300 and CT Scan in Patients with Chronic Schizophrenia
1987
A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy
1990
Brainstem impairment in multiple sclerosis: an assessment by multimodal evoked potentials
1989
Effect of Vigabatrin (Gamma-Vinyl-GABA) on Visual, Brainstem Auditory and Somatosensory Evoked Potentials in Epileptic Patients
1988
Treatment of myasthenia gravis with high-dose intravenous immunoglobulin
1991
Autoimmune myastenia gravis with thymoma following the spontaneous remission of stiff-man syndrome
1990
Effectiveness of steroid treatment in myasthenia gravis: a retrospective study
1991
Prognosis of myasthenia gravis: a retrospective study of 380 patients
1997
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score
2006
MRI and Brainstem Auditory Evoked Potential Evidence of Eighth Cranial Nerve Involvement in Multiple Sclerosis
1997
Steroid-responsive and dependent stiff-man syndrome: A clinical and electrophysiological study of two cases
1988
Short and Long-Term Clinical Effects of Plasma-Exchange in 33 Cases of Myasthenia Gravis
1985
Effects of vigabatrin on evoked potentials in epileptic patients.
1989
Amyotrophic lateral sclerosis: therapeutic, psychological, and research aspects.
1987
Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations
2004
Somatosensory evoked potentials in amyotrophic lateral sclerosis.
1984